University of New England

DUNE: DigitalUNE
Nurse Anesthesia Capstones

School of Nurse Anesthesia

6-2017

Hypertonic Saline Versus Mannitol To Improve
Brain Relaxation In Craniotomy: A Case Study
Morgan Cornell
University of New England

Follow this and additional works at: http://dune.une.edu/na_capstones
Part of the Anesthesiology Commons, and the Nursing Commons
© 2017 Morgan Cornell
Recommended Citation
Cornell, Morgan, "Hypertonic Saline Versus Mannitol To Improve Brain Relaxation In Craniotomy: A Case Study" (2017). Nurse
Anesthesia Capstones. 16.
http://dune.une.edu/na_capstones/16

This Capstone is brought to you for free and open access by the School of Nurse Anesthesia at DUNE: DigitalUNE. It has been accepted for inclusion
in Nurse Anesthesia Capstones by an authorized administrator of DUNE: DigitalUNE. For more information, please contact bkenyon@une.edu.

Running head: HYPERTONIC SALINE VS MANNITOL TO IMPROVE BRAIN RELAXATION

Hypertonic Saline Versus Mannitol to Improve Brain Relaxation in Craniotomy:
A Case Study
Morgan Cornell, BSN, SRNA
Advisor: John Hanlon, DNP, MSNA, CRNA
University of New England

1

HYPERTONIC SALINE VS MANNITOL TO IMPROVE BRAIN RELAXATION
Abstract

2

In neurosurgical procedures, including craniotomy for tumor, neurosurgeons often require a
reduction of brain swelling to optimally perform the surgery. The reduction of brain swelling is
termed brain relaxation. The anesthesia professional can accomplish brain relaxation using
multiple techniques. One such technique is the infusion of certain intravenous fluids to change
the osmotic pressure within the cranial vault thereby reducing brain edema (Jaffe, 2014). Highly
osmolar fluids such as mannitol and hypertonic saline can be infused to decrease brain edema.
Currently, mannitol remains the gold standard for medical treatment of intracranial pressure in
neurosurgical procedures (Marko, 2012). This review seeks to know how hypertonic saline
compares to mannitol to decrease brain edema and improve surgical field conditions in adult
craniotomy patients for tumor resection. Cochrane Collections Plus and MEDLINE were
searched for studies comparing the use of hypertonic saline versus mannitol for brain relaxation.
Both mannitol and hypertonic saline decrease brain edema in the adult craniotomy patient. This
literature review suggests that hypertonic saline significantly improves brain relaxation for
surgeons during craniotomy for tumor resection, while maintaining stable hemodynamics.
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The diagnosis of a brain tumor is a life-altering event, not only for the individual but also
for the entire family. Meningiomas make up 34% of all primary brain tumors, and are most
frequently seen in adults over the age of 60 years old with the incidence increasing with age

(American Brain Tumor Association, 2015). A meningioma is actually a tumor of the meninges,
which is one of the three layers of tissue that surround the brain. This type of tumor is a slow
growing tumor, which may arise from many different areas around the brain. Posterior fossa
tumors account for 10% of all meningiomas, and of those 5 to 11% arise from the petroclivial
region (American Brain Tumor Association, 2015; DiLuna & Bulsara, 2010). Petroclivial
meningiomas are rare brain tumors accounting for only 0.15% of all intracranial tumors. Despite
the rarity of this type of tumor, surgical advances have improved outcomes following resection
of the tumor. According to DiLuna and Bulsara (2010), over 75% of patients return to an
independent functional status at one year. This case study is presented to open discussion
regarding an intervention anesthesia professionals can provide to improve the surgical field, thus
aiding in optimal resection of the tumor.
A seventy-two year-old male presented for a left supine orbitozygomatic craniotomy. The
patient weighed 63 kg and was 167 cm, with a BMI of 22.6. The patient had recent, increasing
forgetfulness and left dull eye pain. He was found to have a left petroclivial meningioma
measuring 4 x 2.6 x 4.8 cm. Other past medical history included hypertension, chronic
obstructive pulmonary disease, and cigarette use. The only past surgical history included a
prostatectomy. He was taking lisinopril, acetaminophen, pantoprazole, atorvastatin, and
cromolyn medications at home. The patient was also started on dexamethasone and
levetiracetam prior to his arrival on the day of surgery. Preoperative laboratory work included a
sodium level of 144mmol/L.

HYPERTONIC SALINE VS MANNITOL TO IMPROVE BRAIN RELAXATION
On the day of surgery, a pre-anesthesia evaluation was performed. The patient was

4

awake and alert. Because the patient’s primary language was not English, his orientation was
difficult to assess. The patient had strong and equal strength in all four extremities. Following
acquisition of appropriate consent for general anesthesia with endotracheal intubation, the patient
was taken to the operating room. Once in the operating room, standard non-invasive monitors
were applied, and oxygen was administered at 10 L/min via mask. After 5 minutes of preoxygenation, the patient was induced with intravenous Fentanyl 250mcg, Lidocaine 100mg,
Propofol 250mg, and Rocuronium 50mg. A size 8 endotracheal tube was then placed using a
Macintosh 3 blade for direct laryngoscopy. Bilateral breath sounds were auscultated and positive
EtCO2 waveform on capnography was noted following placement of the endotracheal tube,
which was then secured in place. The patient was easily ventilated with volume control mode of
ventilation via mechanical ventilator. An arterial catheter was then placed without complication.
General anesthesia was maintained with Isoflurane 0.6% inspired concentration, with a
mixture of 1 L/min of oxygen and 1 L/min of nitrous oxide. Following induction and intubation,
the patient was given dexamethasone 10mg and levetiracetam 1.5gm intravenously. The
operating table was turned 90 degrees, and the surgery was started. Prior to opening of the dura,
as indicated by the surgeon, the patient was given 20% mannitol 30gm intravenous infusion.
EtCO2 was maintained at 25 mm Hg via capnometry. Three hours after the start of surgery an
arterial blood gas was obtained from the arterial line, and resulted at a pH of 7.49, pCO2 of 32,
PaO2 of 104, HCO3 of 24, base excess of 2, ionized calcium of 1.08, lactate of 2.3, and Na of
130mmol/L. The surgeon had difficulty with inadequate relaxation of the brain, and an
additional dose of 20% mannitol 30gm was infused intravenously. Albumin 5% 500 mL was
infused intravenously in two separate doses throughout the case. The total crystalloid infusion
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revealed a pH of 7.47, pCO2 of 32, PaO2 of 147, HCO3 of 23, base excess of 0, ionized calcium
of 1.01, lactate of 2.8, and Na of 130mmol/L. Due to a continued lack of brain relaxation and the
decreased level of sodium at that time, a discussion was had between the anesthesia care team
and the surgeon. The decision was made to initiate hypertonic saline therapy. An infusion of
2% saline was given with a 250 mL IV bolus followed by an infusion. The patient received a
total of 500mL of 2% saline during the case. The patient also received calcium gluconate 3gm
IV and Lasix 10mg IV. An arterial blood gas was obtained two hours after initiation of those
treatments; showing a pH of 7.51, pCO2 of 27, PaO2 of 183, HCO3 of 21, base excess of 0,
ionized calcium of 1.12, lactate of 3.3, and Na of 134mmol/L. An additional dose of
levetiracetam 1gm IV and dexamethasone 10mg IV was also administered at this time.
Following these treatments, the surgeon was able to successfully complete the operation.
Postoperatively, the patient remained stable with vital signs in the intensive care unit
recorded as blood pressure 122/61 mm Hg, heart rate of 69 beats per minute, temperature 37
degrees Celsius, and SpO2 96%. The patient’s postoperative course did include the complication
of speech difficulties, but the patient was discharged home six days after the surgery.
A strong understanding of the anatomy and physiology of the brain and associated
structures is important when providing anesthesia to the neurosurgical patient. Anesthesia
professionals must understand the components of the blood-brain barrier, cerebral metabolism,
and cerebral blood flow in order to properly deliver anesthesia during these specialized cases.
The blood-brain barrier is an exclusive characteristic of the blood vessels in the brain. The
cerebral blood vessels are made up of endothelial cells, which are nearly fused together. The
tight junction of the cells creates a type of lipid barrier. The blood-brain barrier restricts the flow
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Mackey, Wasnick, 2013). An understanding of this concept is critical in understanding the way
that mannitol and hypertonic saline work to decrease brain edema. According to Butterworth et
al. (2013), “The movement of a given substance across the blood-brain barrier is governed
simultaneously by its size, charge, lipid solubility, and degree of protein binding in blood.” The
large molecules of mannitol are unable to cross the blood-brain barrier, and sodium ions are
restricted in their passage. When large amounts of either mannitol or hypertonic saline enter the
blood, stream these substances are unable to cross the blood-brain barrier in the cerebral
vasculature. This creates a hypertonicity of the plasma in the vasculature of the brain. The
hypertonicity results in a transient osmotic gradient, which results in the movement of water out
of the brain parenchyma into the vessels (Butterworth et al, 2013). The water can then be moved
out of the cranial vault and redistributed and excreted from the body.
In order to provide appropriate neuroprotection during neurosurgical cases the anesthesia
professional must understand the normal cerebral metabolism and cerebral blood flow, as well as
the pathophysiology that accompanies anesthesia. Cerebral metabolism is usually expressed as
the rate of oxygen consumption by the brain. Any activity or stimulation of neuronal tissue will
increase the consumption of oxygen, thereby accelerating the cerebral metabolic rate. In fact, up
to 60% of the oxygen consumed by the brain is used to make adenosine triphosphate (ATP) to
support neuronal activity (Butterworth et al., 2013). Nerve activity in the brain is reliant on
oxygen and glucose. There is a tight relationship between the two, in order to maintain
appropriate function of brain activities. When hypoxia ensues there is a lack of oxygen stores in
the brain. The lack of reserve, coupled with the high rate of oxygen consumption by the brain,
quickly lead to unconsciousness and cell death. The brain can also metabolize ketone bodies and
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to cerebral tissue. Cerebral metabolism is closely related to cerebral blood flow. This is termed
flow-metabolism coupling (Barash, Cullen, Stoelting et al., 2013). When there is an increase in
the consumption of oxygen by cerebral tissue, there is a reaction to increase blood flow to the
brain. Conversely, when there is a decrease in cerebral metabolic rate of oxygen consumption,
there is a change in the blood flow to the brain. Cerebral blood flow is not uniform throughout
the entire brain. As different areas require increased oxygen for function, vessels in the brain
distribute blood flow to those areas that require it more. Stimulation and hyperthermia will
elevate cerebral metabolism and blood flow. Conversely, sedation and hypothermia decrease
both the blood flow as well as the cerebral metabolism (Barash et al., 2013). Factors that affect
cerebral blood flow independently from cerebral metabolism include the arterial tension of
carbon dioxide (PaCO2). Cerebral blood flow has a direct relationship with PaCO2. The flow
increases by approximately 3% for every increase in 1mm Hg of PaCO2 (Barash et al., 2013).
Contrary to the direct relationship between PaCO2 and cerebral blood flow, oxygen generally
only affects blood flow at hypoxic levels. When the arterial oxygen tension (PaO2) drops below
50mm Hg, the cerebral blood flow will increase dramatically. Neuronal tissue has high demands
in order to function appropriately, and a frail reserve in the absence of those requirements.
Cerebral blood flow is constant over a wide range of systemic blood pressures. This
maintenance of cerebral blood flow is termed “the auto-regulation plateau” (Barash et al., 2013).
Cerebral blood flow is difficult to measure both directly and indirectly, clinically. Cerebral
blood flow can be conceptualized as the cerebral perfusion pressure. The cerebral perfusion
pressure is the difference between the mean arterial pressure and the intracranial pressure. The
Monroe-Kellie doctrine states that the cranial vault is a fixed volume. Thus, with the change of
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one component, brain parenchyma, blood, or cerebral spinal fluid will necessitate a change in the
volume of the other components. If there is a rise in the intracranial pressure, there must be a
rise in the mean arterial pressure to maintain cerebral perfusion pressure. The cerebral perfusion
pressure remains constant over a range of mean arterial pressures of 60 to 150mm Hg (Barash et

al., 2013). Once these endpoints are reached, cerebral perfusion pressure is directly related to the
cerebral blood flow and mean arterial blood pressure. The exact mechanism that governs the
auto-regulation of cerebral blood flow is not well understood.
Anesthesia greatly affects the cerebral metabolism and cerebral blood flow. Often, the
anesthesia professional will utilize or combat these effects to optimize the patient during the
surgery. All inhalational agents produce a dose-dependent decrease in the cerebral metabolism.
According to Butterworth et al. (2013), isoflurane produces the greatest reduction of cerebral
metabolism. Isoflurane remains the agent of choice for most neuroanesthetists due to this fact.
The flow-metabolism coupling, as described by Barash et al. (2013), remains intact during
inhalational anesthesia. This causes little change in the cerebral blood flow at low doses of
volatile anesthetic. At high doses inhalational agents cause a vasodilatory effect in the cerebral
vasculature, which increases blood flow. An increase in blood flow with minimum alveolar
concentration of volatile anesthetics may cause an increase in intracranial pressure (Butterworth
et al., 2013). Nearly all intravenous agents have little effect on cerebral metabolism and blood
flow. Ketamine is the only intravenous agent that increases cerebral blood flow and intracranial
pressure due to its sympathomimetic properties (Barash et al., 2013). Propofol remains the
induction agent of choice in neurosurgical procedures. Propofol decreases cerebral blood
volume by decreasing cerebral blood flow and cerebral metabolism. This intravenous agent also
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function at the finish of the procedure.
Barash et al. (2013) state that “the fundamental anesthetic considerations in [craniotomy]
for tumor surgery are proper positioning of the patient to facilitate the surgical approach, [and]
providing adequate relaxation of the brain to optimize surgical conditions.” The anesthesia
professional has many tools and techniques to provide the proper brain relaxation to optimize the
surgical field. Dependent upon the required surgical approach, patients may be in supine, lateral,
prone, or sitting positions. In the case study presented, the patient was placed in the supine
position. In this position a head-up tilt with minimal extension or rotation of the neck is
preferred to minimize any venous congestion that may develop in the brain (Barash et al., 2013).
Other techniques to optimize brain relaxation during craniotomy for tumor include
maintenance of PaCO2, temperature, and fluid balance both intra-cranially and systemically.
Due to the direct correlation between PaCO2 and cerebral blood flow as mentioned earlier in this
paper, maintenance of EtCO2 should be between 20-30mm Hg. The effects of decreasing the
EtCO2 to decrease cerebral blood volume are nearly instantaneous. Care should be taken not to
decrease PaCO2 below 20mm Hg and in instances of traumatic brain injury. Marked hypocarbia
may result in cerebral ischemia secondary to an extreme decrease in cerebral blood flow.
Controversy surrounds the use of hyperventilation to decrease brain edema, as it is unclear how
long the effects can last. Although research has shown equilibration can occur between minutes
to hours, clinically the effects of hyperventilation appear to be sustained throughout the
neurosurgical procedure (Barash et al., 2013). Hypothermia causes a decrease in both cerebral
metabolism as well as cerebral blood flow. Although research is clear for the use of hypothermia
in the setting of cardiac arrest, it is less defined for its use as a neuro-protectant in the setting of
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neurosurgical procedures. Nevertheless, research is clear that hyperthermia is detrimental in the
neurological patient. Prudency in the neurosurgical patient is to maintain the patient’s core
temperature at 36 degrees Celsius. Steroids are also helpful in minimizing tumor edema and
pressure (Barash et al., 2013). Finally, the use of hyperosmolar intravenous fluids, as well as
loop diuretics, helps to minimize brain edema and maintain systemic fluid balance. The
appropriate use of these fluids will be more closely examined throughout this paper.
In neurosurgical procedures, including craniotomy for tumor, neurosurgeons often
require a reduction of brain swelling to optimally perform the surgery. The reduction of brain

swelling is termed brain relaxation. The anesthesia professional can accomplish brain relaxation
using multiple techniques. One such technique is the infusion of certain intravenous fluids to
change the osmotic pressure between the brain parenchyma and vasculature thereby reducing
brain edema (Jaffe, 2014). Highly osmolar fluids such as mannitol and hypertonic saline can be
infused to accomplish this change and decrease brain edema.
A literature review was performed to compare hypertonic saline versus mannitol in the
ability to decrease brain edema and improve the surgical field during neurosurgical procedures.
The two databases Cochrane Collection Plus and MEDLINE were searched using keywords
hypertonic saline, mannitol, brain relaxation, and craniotomy. Eight studies were found to be
relevant to the review. One study was an animal study, and the rest were human studies or
systematic reviews including human studies only. In the randomized clinical animal study,
Santacruz et al. (2016) studied the use of hypertonic saline 7.45% versus mannitol 20% to
decrease intracranial hypertension in a small sample of pigs. The sample size was fourteen pigs,
with an additional two animals as control group. This control group, or sham surgery, received
all interventions except the artificially created increase in intracranial pressure. First, the pigs
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parenchymal balloon was placed into the brain in order to artificially raise the intracranial
pressure. The study measured the effects at two different intracranial pressures, 15 and 30 mm
Hg. At an intracranial pressure of 30mm Hg, the animals received one of the two study
solutions. Measurements were taken at the different intracranial pressures, as well as, different
time points. These authors found that at 180 minutes there was a small difference between the
groups, wherein the hypertonic saline maintained a lower intracranial pressure as well as higher
cerebral perfusion pressure. Although Santacruz et al. (2016) admit that these differences were
not statistically significant, when viewing them along with the systematic variables. There are
two large limitations to this study. This is a small animal trial that did not evaluate intracranial
pressure effects of the two groups past 180 minutes.
Due to the limited number of studies, papers researching hypertonic saline versus
mannitol to reduce intracranial pressure in the setting of other neurosurgical procedures and
conditions were also included in this review. Wakai, McCabe, Roberts, and Schierhout (2013)
provided a systematic review in the use of mannitol for acute traumatic brain injury. Kamel,
Navi, Nakagawa, Hemphill III, and Ko (2011) performed a meta-analysis comparing these two
hyperosmolar medications in the setting of elevated intracranial pressure. Finally authors Li, M.,
Chen, Chen, Cai, and Hu (2015) produced a meta-analysis reviewing mannitol versus hypertonic
saline to reduce elevated intracranial pressure in the setting of acute traumatic brain injury.
Wakai et al. (2013) performed an extensive search for randomized controlled trials of the
use of mannitol to treat patients with acute traumatic brain injury. These patients were noted to
be of a variety of severity. Only four studies were found to be inclusive of their selection
criteria. This systematic review was limited in scope to the literature review presented. Firstly,
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it only examined studies where mannitol was the treatment group. Only one of the three studies

compared mannitol to hypertonic saline. The other randomized controlled trials studied mannitol
versus placebo, different dosages, or other medications. Wakai et al. (2013) argued that the
study by Vialet (2003) suggested than mannitol may have a detrimental effect on mortality in
patients with severe head injury as compared to hypertonic saline therapy. Although, Wakai et
al. (2013) admits that the included study (Vialet, 2003) was only single-blinded, too small of a
sample size, and did not evaluate the effects of the osmotic agent on neurological recovery.
Although Wakai et al. (2013) found insufficient evidence to make any recommendations
regarding the use of mannitol in acute traumatic brain injuries; other studies have evaluated the
benefits of hyperosmolar therapy in this population. Kamel et al. (2011) and Li, M. et al. (2015)
included 281 patients over 12 studies to examine the effects of either hypertonic saline or
mannitol on already elevated intracranial pressure. Kamel et al. (2011) performed a metaanalysis evaluating randomized clinical trials that compared hypertonic saline and mannitol in
the treatment of elevated intracranial pressure. These authors included any human subject
receiving equal osmolar doses of hypertonic saline or mannitol in the setting of elevated
intracranial pressure with some form of quantitative intracranial pressure monitor. None of the
studies included in the meta-analysis were blinded. Kamel et al. (2011) also admit that, “all the
trials were small...but several amplified their sample size by including multiple episodes of
elevated ICP per patient.” Finally, the meta-analysis was limited by using each individual
study’s definition of intracranial pressure control. This decision by study authors may have led
to heterogeneity in the analysis causing a bias in the results.
The article by Li, M. et al. (2015) performed a systematic review and meta-analysis to
evaluate equiosmolar doses of hypertonic saline and mannitol in the treatment of elevated
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intracranial pressure after traumatic brain injury. The primary outcome measured by Li, M. et al.
(2015) in all studies was the mean change of intracranial pressure from baseline to the last
measurement after termination of treatment. The authors posit the limitations of their study as
small sample sizes, varied dosages and concentrations of study medications, and causes of brain
injury other than trauma. Finally, the meta-analysis only evaluated the change in intracranial
pressure over time. The article did not evaluate neurological outcomes comparison between the
two treatments. Both of the above mentioned meta-analyses of randomized clinical trials found
hypertonic saline to decrease elevated intracranial pressure over mannitol.
Harutjunyan et al. (2005) is a randomized clinical trial to evaluate hypertonic saline and
hydroxyethyl starch versus mannitol in the treatment of elevated intracranial pressure. The study
evaluated forty neurosurgical patients who were at risk for increased intracranial pressure. Of
the 40 study participants, seventeen patients received the 7.2% hypertonic saline hydroxyethyl
starch 200/0.5 and fifteen patients received 15% mannitol. Eight patients in the study did not
have intracranial pressures greater than twenty, thus did not receive any treatment. The cerebral
perfusion pressure in the hypertonic saline group was statistically higher over the mannitol group
following infusion. This randomized clinical trial also evaluated a secondary outcome of
whether there were any statistically significant changes in blood chemistry following infusion of
either therapy. The study found no significant difference in electrolytes and plasma osmolarity
between the two therapies. Although the authors did study neurosurgical patients, these patients
were intensive care patients with severe neuronal damage. The study evaluated patients with
elevated intracranial pressure, but excluded patients with space-occupying lesions requiring
surgical intervention. Harutjunyan et al. (2005) concluded that hypertonic saline significantly
decreased intracranial pressure over mannitol in their study population.
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and mannitol in the use of brain relaxation for neurosurgical procedures. Vilas Boas, Marques,
and Alves (2011) included 29 patients for elective neurosurgery. Neurosurgical procedures
included elective craniotomy, cerebral aneurysm clipping, arteriovenous malformation repairs,
and cerebral tumor resections. General anesthesia was uniform across all participants provided
as total intravenous anesthesia with propofol and remifentanil infusions. In the study “cerebral
relaxation was evaluated by the same surgeon who was blind to the hyperosmolar therapy”
(Vilas Boas et al., 2011). These authors used equiosmolar infusions of either hypertonic
isoncotic saline or mannitol 20%. Vilas Boas et al. (2011) found no significant difference in the
degree of brain relaxation between the two groups. Although, neurosurgeons did not consider
any patient in the study to be inadequately relaxed, indicating adequacy of both treatments to
provide adequate brain relaxation.
Li, J., Wang, Wang, and Mu (2014) authored a prospective randomized clinical trial to
evaluate the effects of hypertonic saline-hydroxyethyl starch versus mannitol on dural tension
and hemodynamics in patients undergoing elective supratentorial procedures. The authors
evaluated hypertonic saline 7.2% with hydroxyethyl starch 6% against mannitol 20%. Forty
patients undergoing elective supratentorial procedures including resection of gliomas,
meningiomas, or other brain tumors were included in the study. General anesthesia was uniform
among the entire study population. In the clinical trial, approximately thirty minutes prior to
opening of the skull patients received one of two study infusions at a rate of 750mL/hour. A
dural tension score was provided by neurosurgeons. Li, J. et al. (2014) found a statistically
significant decrease in dural tension in the hypertonic saline-hydroxyethyl starch group versus
the mannitol group. They concluded that this effect was prolonged compared to the mannitol

HYPERTONIC SALINE VS MANNITOL TO IMPROVE BRAIN RELAXATION
group. The authors measured mean arterial pressure, heart rate, cardiac index, stroke volume

15

variation, and urine output and found that the hypertonic saline-hydroxyethyl starch group
maintained a more stable hemodynamic profile as compared to the mannitol group as well. Li, J.
et al. (2014) measured serum osmolality in their study as well, and found the maximum to be
330mosm/kg in the hypertonic saline-hydroxyethyl starch group. This number was well within
the current guidelines of maintaining serum osmolality less than 360mosm/kg when using
hypertonic saline infusions.
Prabhaker, Singh, Anand, and Kalaivani (2014) present the most up-to-date and
comprehensive meta-analysis to evaluate mannitol versus hypertonic saline for brain relaxation
in craniotomy patients. This systematic review included 527 patients over 6 randomized clinical
trials. The studies included any adult or pediatric patient of either gender undergoing craniotomy
for brain tumor who received either mannitol or hypertonic saline. The primary outcomes of this
analysis were seeking to find long term outcomes and adverse events following the two treatment
modalities. Unfortunately for Prabhaker et al. (2014), no studies could be found to report the
long term outcomes after either treatment, or fulfill any of the paper’s primary outcomes.
Ultimately, only three of the trials, enrolling 387 patients, reported the outcome of brain
relaxation following either treatment. In fact, in this meta-analysis brain relaxation was only
viewed on a secondary outcome basis. Prabhaker et al. (2014) report that hypertonic saline is
beneficial in producing more effective brain relaxation over mannitol. Although, the authors do
admit that this analysis is concluded from a very limited number of studies. The authors
construe that no heterogeneity was noted among the studies as well. In order to minimize any
bias, two different authors independently reviewed studies for inclusion, exclusion and
assessment of risk of bias.
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producing brain relaxation or decreasing intracranial pressure. In fact, Harutjunyan et al. (2005),
Kamel et al. (2011), Li, J. et al. (2014), Prabhaker et al. (2014), and Li, M. et al. (2015) all
provided evidence that hypertonic saline produces a statistically significant decrease in
intracranial pressure over mannitol. The studies in this literature review also suggest that
hypertonic saline may produce a decrease in intracranial pressure, while maintaining a more
stable hemodynamic state over mannitol. Hypertonic saline provides the volume expansion with
less diuresis as compared to mannitol (Li, J. et al., 2014). The lack of the diuretic effects may
contribute to the hemodynamic stability seen after hypertonic saline infusion.
There may be significant limitations to implementation of the results of this literature
review into clinical practice. There are limited studies evaluating the outcome of brain
relaxation following hypertonic saline or mannitol. Currently, all studies reviewed by this author
were of limited sample size as well. Mannitol is available as 20% and 25% solutions. It is
infused at doses ranging from 0.25 to 1gm/kg. Hypertonic saline is available in multiple
concentrations including 2%, 3%, 5%, 7.5%, and 23% (Prabhaker et al., 2014). Hypertonic
saline has the theoretical risk of causing endothelial damage at the catheter insertion site in
peripheral veins, especially in the setting of extravasation (Johnson & Criddle, 2004). Most
institution will not infuse hypertonic saline in concentrations above 3% without central vascular
access. Risks versus benefits of placing central vascular access must be evaluated should higher
concentrations of hypertonic saline be considered to enhance brain relaxation. Hypertonic saline
can be administered as an intravenous bolus or infusion. Limited study sample sizes and variable
dosage of hypertonic saline are the two major factors that provide limitations to this literature
review.
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In order to overcome these limitations, there is ample room for future research. Evidence
regarding optimal concentration of hypertonic saline must be obtained. Li, M. et al. (2015) and

Vilas Boas et al. (2011) were the only two studies in this review to evaluate equiosmolar doses of
hypertonic saline and mannitol. Standardization of osmolarity for evaluation of hypertonic
saline versus mannitol must be achieved in order to adequately evaluate clinical trials. Studies
must be adequately powered. Large, multi-center randomized clinical trials are recommended in
order to increase the evidence for or against the recommendation to make hypertonic saline the
“gold standard” for decreasing intracranial pressure in the setting of all neurosurgical procedures.
Using the case study above assists the anesthesia professional to correlate evidence with
practice. No premedication was used on this patient. As discussed above, PaCO2 has a direct
correlation with cerebral blood flow. Any type of premedication may cause respiratory
depression, which would lead to increased intracranial pressure as a result of the hypercarbia.
The induction of anesthesia and intubation of the trachea occurred without incident. An
adequate dose of opioid, in conjunction with propofol, was used to blunt the sympathetic
response and provide an adequate depth of anesthesia to prevent any hypertension during
tracheal intubation. Butterworth et al. (2013) describes how hypertension leads to an increase in
cerebral blood volume, which increases intracranial pressure. This increase in pressure could be
detrimental in patients with decrease cranial compliance due to an existing tumor. The patient’s
head was positioned in order to provide surgical access, while still minimizing any type of
venous congestion.
Many lessons can be learned from the case study presented above. Interventions as
previously discussed were implemented to provide neuroprotection, as well as optimize brain
relaxation. The patient was given intravenous dexamethasone to decrease tumor edema. The
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patient was maintained euthermic throughout the case. Preventing any type of hyperthermia was
one factor in maintaining optimal neuroprotection (Barash et al., 2013). Isoflurane and nitrous
oxide inhalational agents were used to maintain adequate depth of anesthesia during the
maintenance phase of the case. The patient was maintained on mechanical ventilation with tidal
volumes at approximately 6mL/kg. High mean airway pressure, as a result of large tidal
volumes, could lead to increased intracranial pressure by increasing central venous pressure in

the thoracic cavity (Butterworth et al., 2013). PaCO2 was maintained at 25-35mm Hg with these
ventilation strategies as well. This strategy limited the increase in cerebral blood flow in
correlation with the low PaCO2 to aid in brain relaxation.
Multiple considerations can be made when reviewing the literature against the timeline of
the case study presented. First, a tight control of blood glucose is important to provide adequate
neuroprotection. The brain relies heavily on a constant supply of glucose to perform neuronal
activity. Yet, as discussed earlier, hyperglycemia can lead to ischemia. It is understood as
described by Butterworth et al. (2013) that, “hyperglycemia is common in neurosurgical patients
(corticosteroid effect) and has been implicated in increasing ischemic brain injury.” Blood
glucose was not assessed regularly throughout this case. Barash et al. (2013) suggest
maintaining a range of glycemic control of 140 to 180mg/dl. While reviewing the literature the
majority of studies advocate for the use of hypertonic saline to optimize brain relaxation.
In the case study hyponatremia was identified by arterial blood gas. The surgeon
repeatedly stated difficulty with inadequate brain relaxation, despite the anesthesia professionals
continued interventions. This author proposes in light of the evidence that hypertonic saline
initiated at the start of the case may have improved surgical conditions earlier, which would have
decrease the interventions provided. Notwithstanding the lack of evidence in the use of either
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evidence that the use of hypertonic saline may improve brain relaxation. All medications have
consequences.
The patient in the case study required increased crystalloid, colloid, and vasopressor
administration for decreasing mean arterial blood pressure intra-operatively. The decrease of the
mean arterial pressure may lead to a decrease in cerebral perfusion pressure. Li, J. et al. (2014)
found that patients who received hypertonic saline-hydroxyethyl starch actually had an increase
in their mean arterial pressure. These authors refer to related studies, which show that an
infusion of hypertonic saline could quadruple intravascular volume. Even after four hours
following a bolus dose the plasma volume remains increased by 750mL for every one liter of
hypertonic saline administered. Li, J. et al. (2014) found a decrease in the diuretic effect of
hypertonic saline infusions, which would avoid hypovolemia and hypotension in the
neurosurgical patient. The patient in the case study may have avoided excess crystalloid and
colloid fluid administration had hypertonic saline therapy been initiated earlier in the case. The
patient could have avoided a possible decrease in their cerebral perfusion pressure due to
hypotension. Patients with cerebral perfusion pressures below 50mm Hg show changes in their
EEG, progressing with depreciating cerebral perfusion pressure ultimately to irreversible
neuronal death (Butterworth et al., 2013).
In the presented case, could the surgical time have been shortened or resection improved
with the use of hypertonic saline at the start of the case in place of the mannitol? The evidence
suggests that this may be the case. Despite the delay in recognizing the need for hypertonic
saline therapy, it was finally initiated. Vilas Boas et al. (2011) recommend serum sodium should
not be increased greater than 20mEq per day. The case study saw an increase similar to their
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study. Vilas Boas et al. (2011) saw a mean increase in serum sodium of 4.56mEq thirty minutes

after administration of hypertonic isoncotic saline therapy. These authors also note that an acute
increase up to 160mEq serum sodium have been tolerated without harm in patients. The patient
was discharged home with minor neurological deficits. As anesthesia professional encountering
an aging population globally, neurosurgical procedures will continue to occur. The highest level
of evidence-based practice must be implemented in order to optimize patient outcomes following
neurosurgical procedures.
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